Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Ophthalmology therapeutics Market Research Reports

Titlepublishedprice

Diffuse Posterior Uveitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... obe. A key objective of the Diffuse Posterior Uveitis Report is to understand the market and pipeline status of the drugs around the Diffuse Posterior Uveitis to explore the generic development opportunities, licensing opportunities and to gain compe......"
01-Sep-2016$2000

Glaucoma  - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... nited States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Glaucoma forecasted market share for ten years to 2023 segmented by seven major market......"
01-Sep-2016$4950

Allergic Conjunctivitis  - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... or markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Allergic Conjunctivitis forecasted market share for ten years to 2023......"
01-Sep-2016$4950

Allergic Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... e. A key objective of the Allergic Conjunctivitis Report is to understand the market and pipeline status of the drugs around the Allergic Conjunctivitis to explore the generic development opportunities, licensing opportunities and to gain competitive......"
01-Sep-2016$2000

Bacterial Conjunctivitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... be. A key objective of the Bacterial Conjunctivitis Report is to understand the market and pipeline status of the drugs around the Bacterial Conjunctivitis to explore the generic development opportunities, licensing opportunities and to gain competit......"
01-Sep-2016$2000

Herpes Zoster Ophthalmicus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... lobe. A key objective of the Herpes Zoster Ophthalmicus Report is to understand the market and pipeline status of the drugs around the Herpes Zoster Ophthalmicus to explore the generic development opportunities, licensing opportunities and to gain co......"
01-Sep-2016$2000

Glaucoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ive of the Glaucoma Report is to understand the market and pipeline status of the drugs around the Glaucoma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. ......"
01-Sep-2016$2000

Macular Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... bjective of the Macular Edema Report is to understand the market and pipeline status of the drugs around the Macular Edema to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeli......"
01-Sep-2016$2000

Keratitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... tive of the Keratitis Report is to understand the market and pipeline status of the drugs around the Keratitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategie......"
01-Sep-2016$2000

Keratoconjunctivitis sicca (Dry Eye)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ross the globe. A key objective of the Keratoconjunctivitis sicca (Dry Eye) Report is to understand the market and pipeline status of the drugs around the Keratoconjunctivitis sicca (Dry Eye) to explore the generic development opportunities, licensin......"
01-Sep-2016$2000